The effects of intravaginal clindamycin and metronidazole therapy on vaginal lactobacilli in patients with bacterial vaginosis

American Journal of Obstetrics and Gynecology

Volumn 194, Issue 5, 2006, Pages 1277-1282

  Nyirjesy, Paul ^a   McIntosh, Matthew J ^b   Gattermeir, David J ^b   Schumacher, Robert J ^b   Steinmetz, Jana I ^b   Joffrion, James L ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b KV Pharmaceutical Company   (United States)

Author keywords

Bacterial vaginosis; Clindamycin; Lactobacillus; Metronidazole; Vaginitis

Indexed keywords

CLINDAMYCIN; CLINDAMYCIN PHOSPHATE; METRONIDAZOLE;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CREAM; DRUG EFFECT; FEMALE; HUMAN; LACTOBACILLUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; VAGINITIS;

ADMINISTRATION, INTRAVAGINAL; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; CLINDAMYCIN; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LACTOBACILLUS; METRONIDAZOLE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; VAGINA; VAGINOSIS, BACTERIAL;

EID: 33646078577     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2005.11.006     Document Type: Article

References (23)

1. Sobel J.D. Vaginitis. N Engl J Med 337 (1997) 1896-1903
2. Beigi R.H., Austin M.N., Meyn L.A., Krohn M.A., and Hillier S.L. Antimicrobial resistance associated with the treatment of bacterial vaginosis. Am J Obstet Gynecol 191 (2004) 1124-1129
3. Koumans E.H., and Kendrick J.S. CDC Bacterial Vaginosis Working Group. Preventing adverse sequelae of bacterial vaginosis: a public health program and research agenda. Sex Transm Dis 28 (2001) 292-297
4. Ness R.B., Hillier S.L., Richter H.E., Soper D.E., Stamm C., McGregor J., et al. Douching in relation to bacterial vaginosis, lactobacilli, and facultative bacteria in the vagina. Obstet Gynecol 100 (2005) 765-772
5. Bartlett J.G., Onderdonk A.B., Drude E., Goldstein C., Anderka M., Alpert S., et al. Quantitative bacteriology of the vaginal flora. J Infect Dis 136 (1977) 271-277
6. Wilks M., and Tabaqchali S. Quantitative bacteriology of the vaginal flora during the menstrual cycle. J Med Microbiol 24 (1987) 241-245
7. Eschenbach D.A., Thwin D.A., Patton D.L., Hooton T.M., Stapleton A.E., Agnew K., et al. Influence of the normal menstrual cycle on vaginal tissue, discharge, and microflora. Clin Infect Dis 30 (2000) 901-907
8. Simoes J.A., Aroutcheva A.A., Schott S., and Faro S. Effect of metronidazole on the growth of vaginal lactobacilli in vitro. Infect Dis Obstet Gynecol 9 (2001) 41-45
9. Bayer A.S., Chow A.W., Concepcion N., and Guze L.B. Susceptibility of 40 lactobacilli to six antimicrobial agents with broad gram-positive anaerobic spectra. Antimicrob Agent Chemother 14 (1978) 720-722
10. Aroutcheva A., Simoes J.A., Schott S., and Faro S. The inhibitory effect of clindamycin on Lactobacillus in vitro. Infect Dis Obstet Gynecol 9 (2001) 239-244
11. Agnew K.J., and Hillier S.L. The effect of treatment regimens for vaginitis and cervicitis on vaginal colonization by lactobacilli. Sex Transm Dis 22 (1995) 269-273
12. Hillier S.L., Lipinski C., Briselden A.M., and Eschenbach D.A. Efficacy of intravaginal 0.75% metronidazole gel for the treatment of bacterial vaginosis. Obstet Gynecol 81 (1993) 963-967
13. Guidance for Industry: Bacterial Vaginosis-Developing Antimicrobial Drugs for Treatment. Draft Guidance. US Dept of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER); July 1998.
14. Amsel R., Totten P.A., Spiegel C.A., Chen K.C., Eschenbach D., and Holmes K.K. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. Am J Med 74 (1983) 14-22
15. Nugent R.P., Krohn M.A., and Hillier S.L. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of Gram stain interpretation. J Clin Microbiol 29 (1991) 297-301
16. Hawes S.E., Hillier S.L., Benedetti J., Stevens C.E., Koutsky L.A., Wolner-Hanssen P., et al. Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 174 (1996) 1058-1063
17. Andres F.J., Parker R., Hosein I., and Benrubi G.I. Clindamycin vaginal cream versus oral metronidazole in the treatment of bacterial vaginosis: a prospective double-blind clinical trial. South Med J 85 (1992) 1077-1080
18. Schmitt C. Bacterial vaginosis: treatment with clindamycin cream versus oral metronidazole. Obstet Gynecol 79 (1992) 1020-1023
19. Ferris D.G., Litaker M.S., Woodward L., Mathis D., and Hendrich J. Treatment of bacterial vaginosis: a comparison of oral metronidazole, metronidazole vaginal gel, and clindamycin vaginal cream. J Fam Pract 4 (1995) 443-449
20. Paavonen J., Mangioni C., Martin M.A., and Wajszczuk C.P. Vaginal clindamycin and oral metronidazole for bacterial vaginosis: a randomized trial. Obstet Gynecol 96 (2000) 256-260
21. Fischbach F., Petersen E.E., Weissenbacher E.R., Martius J., Hosmann J., Mayer H., et al. Effect of clindamycin cream versus oral metronidazole in the treatment of bacterial vaginosis. Obstet Gynecol 82 (1993) 405-410
22. Faro S., Skokos C.K., and Clindesse Investigators Group. The efficacy and safety of a single dose of Clindesse™ vaginal cream versus a seven-dose regimen of Cleocin® vaginal cream in patients with bacterial vaginosis. Infect Dis Obstet Gynecol 13 (2005) 155-160
23. Eriksson K., Carlsson B., Forsum U., and Larsson P.G. A double-blind treatment study of bacterial vaginosis with normal vaginal lactobacilli after an open-label treatment with vaginal clindamycin ovules. Acta Derm Venereol 85 (2005) 42-46